Quantcast

Evolocumab Articles

Cholesterol Drug by Amgen Cuts LDL by 60%

A new class of experimental drugs have been proven to dramatically lower cholesterol, and may become a viable option for the 70 million Americans who have high LDL (low-density lipoprotein) or “bad” cholesterol. One of these new medicines, Amgen’s Evolocumab, …